Co-Administration of An Agent Linked to an Internalization Peptide With an Anti-Inflammatory
AssigneeNoNO Inc.
InventorsMichael Tymianksi, Jonathan David Garman
Life of this patent
Estimating the term…
Loading patent…
AssigneeNoNO Inc.
InventorsMichael Tymianksi, Jonathan David Garman
Estimating the term…
The invention provides methods of delivering pharmacologic agents linked to an internalization peptide, in which an inflammatory response inducible by the internalization peptide is inhibited by co-administration of an anti-inflammatory or by linking the internalization peptide to biotin or similar molecule. Such methods are premised in part on the results described in the examples whereby administration of a pharmacological agent linked to tat at high dosages is closely followed by an inflammatory response, which includes mast cell degranulation, histamine release and the typical sequelae of histamine release, such as redness, heat, swelling, and hypotension.
A method of inhibiting cerebral ischemia due to endovascular surgery, comprising:
(canceled)
A method of treating or effecting prophylaxis of a disease mediated by excitotoxicity comprising
A peptide having an amino acid sequence consisting of or comprising (RRRQRRKKRGYKLSSIESDV SEQ ID NO:70), optionally formulated with a physiologically acceptable carrier as a pharmaceutical composition.
A method of delivering a pharmacologic agent to a subject, the method comprising:
The method of claim 48, wherein the mast cell degranulation inhibitor is administered at the same time as or up to 15 minutes before the pharmacological agent.
The method of claim 48, wherein the mast cell degranulation inhibitor is co-formulated with the pharmacologic agent.
The method of claim 48, for treating or prophylaxis of a disease mediated by excitotoxicity in the subject.
A kit comprising a pharmacological agent linked to an internalization peptide, and lodoxamide.
36-39. (canceled)
A co-formulation comprising lodoxamide and a peptide having an amino acid sequence of SEQ ID NO:6 (YGRKKRRQRRRKLSSIESDV) and water.
A method of delivering a pharmacological agent linked to an internalization peptide to a population of subjects having or a risk of a disease treatable by the pharmacological agent, comprising
A method of treating or effecting prophylaxis of a disease mediated by excitotoxicity comprising
A method of delivering a pharmacological agent linked to an internalization peptide to a subject having or a risk of a disease treatable by the pharmacological agent, comprising
Dependencies are inferred from the claim text.